Ultrasonographic Air Bronchogram in Pediatric CAP
Launched by CATHOLIC UNIVERSITY OF THE SACRED HEART · Jun 4, 2018
Trial Information
Current as of May 28, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a specific ultrasound technique, called the air bronchogram, can help doctors understand and manage pneumonia in children. The researchers want to see if changes in this ultrasound finding can provide important information about how well a child is responding to treatment for community-acquired pneumonia (CAP), which is a type of lung infection.
The trial is looking for children between the ages of 1 and 16 who are suspected of having pneumonia and are being admitted to a pediatric unit. To participate, children need to have evidence of lung problems on their X-ray, and their parents must give written permission. If you decide to participate, your child will undergo an ultrasound to look at their lungs, which is a safe and painless procedure. It’s important to note that children with certain conditions, like cystic fibrosis or serious lung diseases, won’t be eligible for this study. If you have questions or are interested in this trial, please speak with your healthcare provider for more details.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Suspected CAP
- • Age from 1 to 16 years old
- • Admission to Pediatric Unit
- • Radiographic evidence of lung consolidation
- • Written informed consent from parents
- Exclusion Criteria:
- • Gestational age \< 36 weeks
- • Previous diagnosis of cystic fibrosis
- • Congenital pulmonary disease.
- • Refusal to participate.
About Catholic University Of The Sacred Heart
The Catholic University of the Sacred Heart is a prestigious academic institution in Italy, renowned for its commitment to advancing medical research and education. With a strong emphasis on ethical standards and community well-being, the university actively engages in clinical trials that contribute to innovative healthcare solutions. Its multidisciplinary approach leverages expertise from various fields, fostering collaborations that enhance the quality and impact of research. The university is dedicated to improving patient outcomes through rigorous science and compassionate care, aligning with its mission to serve the greater good.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Roma, , Italy
Trieste, , Italy
Patients applied
Trial Officials
Luca Richeldi, Prof,MD,PhD
Study Director
Fondazione Policlinico Universitario A. Gemelli, IRCCS
Riccardo Inchingolo, MD, PhD
Principal Investigator
Fondazione Policlinico Universitario A. Gemelli, IRCCS
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials